Skip to main content
. 2023 Feb 10;9(2):e13570. doi: 10.1016/j.heliyon.2023.e13570

Table 1.

Binding assay of Vedolizumab by using Cell based ELISA and Flow cytometry.

Validation parameter Mean Standard Deviation % GCV Geometric mean Relative biasness %RSD
Cell based ELISA 101.8 0.34 0.349 101.16 8.68 0.074%
Flow Cytometry 108 1.63 1.63 108.68 7.90 0.346%